United States Health Information Knowledgebase

 

HITSP C87 Anonymize Public Health Case Reporting Data Component


Type:Data Agreement
Start Date:2008-12-18
Scope:This construct provides guidance for anonymization and should be implemented with consideration of risk assessment results in the intended operating environment. This construct is intended specifically for the use of anonymizing public health case reporting data, and should not be reused for any other purpose.

The Health Insurance Portability and Accountability Act of 1996 (HIPAA) regulation in 45 CFR 164.512(a) states, “a covered entity may use or disclose protected health information to the extent that such use or disclosure is required by law and the use or disclosure complies with and is limited to the relevant requirements of such law.”

HITSP interprets the rule to permit covered entities to disclose protected health information without authorization for specified public health purposes. However, this permissiveness is not a request to any and all data. In practice, public health supports such data requests with rational supporting justification. This commonly takes the form of state or local legislation declaring the types of data, or specific data elements required for public health. HITSP recommends that all implementations undergo legal review to ensure compliance with local, state, and federal regulations. HITSP supports further harmonization of policy and practices for more uniform public health data exchange.

Disclosure of patient identifiable data to public health authorities in the context of reportable conditions monitoring is routine; this disclosure is based upon the need to monitor and manage known public health threats. Public health systems collect a broad variety of healthcare data that may go beyond capturing data to support assessment of known threats. As such, HITSP supports the use of anonymization and pseudonymization approaches to protect individual privacy and confidentiality. This Component specifies anonymization protections for such data collection.

Under 45 CFR 164.502(d), HIPAA defines 18 data elements that under a Safe Harbor approach must be removed from personal health records in order for those records to be considered anonymized. The Use

HITSP Anonymize Public Health Case Reporting Data Component

Released for Implementation

20081218 V 1.0 7

Case has defined some demographic data elements of interest that need to be retained in order to accurately evaluate the data for public health case reporting. This Component specifies removal and aggregation requirements for data variables submitted to a Public Health Information System.

The selected standard is the International Organization for Standardization (ISO) Health informatics -- Pseudonymisation, Unpublished Technical Specification # 25237 (ISO TS25237). This standard defines 3 levels of anonymization, with specific requirements for anonymization at each one of those anonymization levels. These requirements are described in Section 2.2.
Downloads
PDF
Download as a PDF file.
[Download PDF Reader Exit Disclaimer]
Download as an MS Excel™ spreadsheet.
[Download Excel Reader Exit Disclaimer]
Relationship Organization Item
Is composed of HITSP Address   
Is composed of HITSP Administration of Treatment   
Is composed of HITSP Admission Date   
Is composed of HITSP Adverse Event (AE) Terms   
Is composed of HITSP AE Following Prior Vaccination   
Is composed of HITSP Age   
Is composed of HITSP Approximate Age of Device   
Is composed of HITSP Birth Weight   
Is composed of HITSP Common Device Name   
Is composed of HITSP Concomitant Medical Product Name   
Is composed of HITSP Concomitant Medical Products & Therapy Dates   
Is composed of HITSP Contact Person   
Is composed of HITSP Contact Phone Number   
Is composed of HITSP Current Medications (Medwatch concomitant meds)   
Is composed of HITSP Date of Birth   
Is composed of HITSP Date of Death   
Is composed of HITSP Date of Event   
Is composed of HITSP Date of Test   
Is composed of HITSP Date product returned to manufacturer   
Is composed of HITSP Date Report Sent   
Is composed of HITSP Date Sent to FDA   
Is composed of HITSP Date Treatment was Administered   
Is composed of HITSP Date User Facility/Importer Became Aware of Event   
Is composed of HITSP Death   
Is composed of HITSP Description of Event   
Is composed of HITSP Diagnosis Date/Time   
Is composed of HITSP Diagnosis Type   
Is composed of HITSP Diagnosis/Injury Code   
Is composed of HITSP Discharge Date   
Is composed of HITSP Discharge Date   
Is composed of HITSP Estimated Delivery Date   
Is composed of HITSP Ethnicity   
Is composed of HITSP Event Abated after use stopped or dose reduced   
Is composed of HITSP Event Device Problem Code   
Is composed of HITSP Event Reappeared after reintroduction   
Is composed of HITSP Expiration Date   
Is composed of HITSP Facility Identifier   
Is composed of HITSP Facility Identifier   
Is composed of HITSP Facility/Importer Name   
Is composed of HITSP Gender   
Is composed of HITSP Hospital Name   
Is composed of HITSP Hospitalization   
Is composed of HITSP If explanted give date   
Is composed of HITSP If implanted give date   
Is composed of HITSP Location where Event Occurred   
Is composed of HITSP Manufacturer Name, City and State   
Is composed of HITSP Medical Device Catalog #   
Is composed of HITSP Medical Device Lot #   
Is composed of HITSP Medical Device Model #   
Is composed of HITSP Medical Device Other #   
Is composed of HITSP Medical Device Serial #   
Is composed of HITSP Name and Address of Reprocessor   
Is composed of HITSP Name of Condition   
Is composed of HITSP Name of Organization Collecting Specimen   
Is composed of HITSP Name of Treatment   
Is composed of HITSP NDC# or Unique ID   
Is composed of HITSP Number of Siblings   
Is composed of HITSP Occupation   
Is composed of HITSP Occupation of Reporter   
Is composed of HITSP Operator of Device   
Is composed of HITSP Ordered Test Code   
Is composed of HITSP Outcome Attributed to AE   
Is composed of HITSP Patient Address (street name, city, state, zip code)   
Is composed of HITSP Patient Class   
Is composed of HITSP Patient Country   
Is composed of HITSP Patient County   
Is composed of HITSP Patient identifier   
Is composed of HITSP Patient Name (first, MI, Last)   
Is composed of HITSP Patient Recovered Diagnosis   
Is composed of HITSP Patient Telephone   
Is composed of HITSP Performing Laboratory   
Is composed of HITSP Pre-existing physician diagnosed allergies, birth defects. Medical conditions   
Is composed of HITSP Pregnancy Status   
Is composed of HITSP Previous Event Report Details   
Is composed of HITSP Previous Vaccine Date Given   
Is composed of HITSP Previous Vaccine Lot #   
Is composed of HITSP Previous Vaccine Manufacturer   
Is composed of HITSP Previous Vaccine Route   
Is composed of HITSP Previous Vaccine Route/Site   
Is composed of HITSP Previous Vaccine Type   
Is composed of HITSP Product available for evaluation?   
Is composed of HITSP Product Diagnosis for Use   
Is composed of HITSP Product Dose   
Is composed of HITSP Product Frequency   
Is composed of HITSP Product Lot #   
Is composed of HITSP Product Route Used   
Is composed of HITSP Product Therapy Dates   
Is composed of HITSP Race   
Is composed of HITSP Reason for Non-Evaluation   
Is composed of HITSP Recovered   
Is composed of HITSP Report Date   
Is composed of HITSP Report sent to   
Is composed of HITSP Report sent to FDA   
Is composed of HITSP Report Source   
Is composed of HITSP Report Source   
Is composed of HITSP Reported Previously   
Is composed of HITSP Reporter Address (street name, city, state, zip code)   
Is composed of HITSP Reporter Email   
Is composed of HITSP Reporter Name   
Is composed of HITSP Reporting Laboratory Identifier   
Is composed of HITSP Responsible Physician/Healthcare Provider Name   
Is composed of HITSP Result Unit   
Is composed of HITSP Resulted Test   
Is composed of HITSP Results Status   
Is composed of HITSP Signs and Symptoms   
Is composed of HITSP Single use device that was reprocessed and reused on patient   
Is composed of HITSP Source of Specimen   
Is composed of HITSP Specimen Collection Date   
Is composed of HITSP Suspect Medical Device Brand Name   
Is composed of HITSP Suspect Product Name   
Is composed of HITSP Symptom/ Illness Onset Date/Time   
Is composed of HITSP Telephone   
Is composed of HITSP Test Interpretation   
Is composed of HITSP Test Method   
Is composed of HITSP Test Result   
Is composed of HITSP Test Status   
Is composed of HITSP Therapy Dates   
Is composed of HITSP Type of Event and/or Issue   
Is composed of HITSP Type of Follow-Up   
Is composed of HITSP Type of Remedial Action   
Is composed of HITSP Type of Report   
Is composed of HITSP Type of Reportable Event   
Is composed of HITSP Type of Reporter   
Is composed of HITSP User Facility/Importer Report Number   
Is composed of HITSP Vaccine # Previous Doses   
Is composed of HITSP Vaccine Purchased With   
Is composed of HITSP Weight   
Relationship Organization Item
is composed of HITSP Data Mapping Level 1 Patient Data Elements (C87)   

There are no Value Domains linked to HITSP C87 Anonymize Public Health Case Reporting Data Component.

HITSP Acronyms List
HITSP Harmonization Framework
HITSP Interoperability Specification Overview
HITSP TN 901 -Technical Note for Clinical Documents
Security and Privacy Technical Note
Scroll To Top